Use of nitric oxide-releasing agents for reducing metastasis ris

Details Use of nitric oxide-releasing agents for reducing metastasis ris Use of nitric oxide-releasing agents for reducing metastasis ris

1994-11-22

1997-12-23

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

5142312, 514315, 514255, 514611, A61K 3140, A61K 31535, A61K 31445, A61K 31495, A61K 3113

Patent

active

057008302

ABSTRACT:
A method for inhibiting the adherence between cancerous cells and noncancerous structures in a mammal, comprising the administration to the mammal of a nitric oxide-releasing compound containing a nitric oxide-releasing N.sub.2 O.sub.2.sup.- functional group. The compound is capable of releasing an adherence-inhibiting effective amount of nitric oxide to the mammal.

REFERENCES:
patent: 5212204 (1993-05-01), Keefer et al.
patent: 5250550 (1993-10-01), Keefer et al.

Affiliated with

Also associated with

Rating

Use of nitric oxide-releasing agents for reducing metastasis ris does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of nitric oxide-releasing agents for reducing metastasis ris, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nitric oxide-releasing agents for reducing metastasis ris will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1803110